Repeat Conjunctival Biopsy after Immunomodulatory Therapy for Ocular Mucous Membrane Pemphigoid

Ocul Immunol Inflamm. 2018;26(1):70-73. doi: 10.1080/09273948.2016.1194435. Epub 2016 Jul 20.

Abstract

Purpose: To evaluate whether conjunctival biopsy findings in patients with ocular mucous membrane pemphigoid (MMP) persist as positive or revert to negative following treatment with immunomodulatory therapy (IMT).

Methods: Patients with biopsy-proven MMP were treated with IMT for at least 2 years before undergoing repeat conjunctival biopsy for immunofluorescence microscopy. Their records were reviewed and findings evaluated to ascertain which patients' biopsies showed antibody deposition on the conjunctival basement membrane.

Results: Following 2 years of IMT, conjunctival biopsies showed persistent antibody deposition in two patients, and were negative in four patients.

Conclusions: Conjunctival biopsies in patients with ocular MMP may show reversion to inactive disease following IMT. Post-treatment biopsy might be clinically useful as a means of evaluating the efficacy of therapy in this chronic disease.

Keywords: Conjunctiva; immunofluorescence; immunomodulatory therapy; mucous membrane; pemphigoid.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Azathioprine / therapeutic use
  • Biopsy
  • Conjunctiva / pathology*
  • Conjunctival Diseases / diagnosis
  • Conjunctival Diseases / therapy*
  • Cyclophosphamide / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Immunomodulation*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Microscopy, Fluorescence
  • Middle Aged
  • Mycophenolic Acid / therapeutic use
  • Pemphigoid, Benign Mucous Membrane / diagnosis
  • Pemphigoid, Benign Mucous Membrane / therapy*

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide
  • Mycophenolic Acid
  • Azathioprine